High-stakes PCSK9 patent case hits court, and oddsmakers weigh the arguments for winner
admin 7th June 2017 Uncategorised 0Predicting a court’s decision based on oral arguments is a dicey-yet-irresistible proposition. Just check out the chatter after Tuesday’s much-anticipated PCSK9 patent hearing. Some analysts and experts gave Amgen the best shot—up to 80% odds of winning, in fact. Others figure Sanofi and Regeneron have the edge.
More: High-stakes PCSK9 patent case hits court, and oddsmakers weigh the arguments for winner
Source: fierce